Correction: Treatment-free remission after a second TKI disc…

Emerging


0
Citations
0
Refs
2024
Year
Search Works
Work Details
MENU
0

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Erratum 2024 EN Hybrid

“TFR probability at 6, 12 and 24 months was 62, 55 and 42%respectively”, the figure should have appeared as shown below:

0

Citations

0

References

20

Authors

0.00

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
20 authors
#AuthorInstitutionsORCID
1 Hjalmar Flygt Corresponding Uppsala University Hospital (SE)
2 Stina Söderlund Uppsala University Hospital (SE) —
3 Johan Richter Skåne University Hospital (SE)
4 Susanne Saußele Heidelberg University (DE) Medizinische Fakultät Mannheim (DE)
5 Perttu Koskenvesa Helsinki University Hospital (FI)
6 Leif Stenke Karolinska University Hospital (SE) Karolinska Institutet (SE)
7 Satu M. Mustjoki University of Helsinki (FI) Helsinki University Hospital (FI)
8 Andreja Dimitrijevic Odense University Hospital (DK)
9 Jesper Stentoft Aarhus University Hospital (DK)
10 Waleed M. Majeed Stavanger University Hospital (NO)
11 Lydia Roy Université Paris-Est Créteil (FR) Assistance Publique – Hôpitaux… (FR) +2
12 Dominik Georg Friedrich Wolf Innsbruck Medical University (AT) Universität Innsbruck (AT) +2
13 Arta Dreimane Linköping University Hospital (SE) —
14 Bjørn Tore Gjertsen Haukeland University Hospital (NO)
15 Tobias Gedde‐Dahl Oslo University Hospital (NO)
16 Erik Ahlstrand Örebro University (SE)
17 Berit Markevärn University Hospital of Umeå (SE) —
18 Henrik Hjorth‐Hansen St Olav's University Hospital (NO)
19 Jeroen J. W. M. Janssen Radboud University Medical Cen… (NL)
20 Ulla Olsson‐Strömberg Uppsala University Hospital (SE) —

Data: OpenAlex